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Surgical Techniquesto septal myectomy, significant decreases in residual SAM
and superior hemodynamic results have been observed.4
In summary, we report the case of a patient with HOCM
previously treated with PTSMA but with residual LVOTO
caused by SAM. We successfully performed an isolated
mitral valve leaflet extension to address the mitral valve ap-
paratus abnormalities. This case report illustrates the impor-
tance of surgically treating the mitral valve apparatus in
addition to septal myectomy when treating patients with
HOCM for LVOTO caused by SAM.
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15 years. J Thorac Cardiovasc Surg. 1989;97:666-74.Transapical double valve implantation plus percutaneous
revascularization as a bailout for a high-risk patientDavid M. Holzhey, MD, Gerhard Schuler, MD, PhD, Friedrich W. Mohr, MD, PhD, and
Chirojit Mukherjee, MD, Leipzig, GermanyTranscatheter aortic valve implantation as a treatment op-
tion for severe aortic valve stenosis has become a routine
procedure, with encouraging results in a high-risk popula-
tion.1,2 Concomitant treatment of coronary artery disease
by percutaneous intervention has been described,3 and sin-
gle cases and small series of transcatheter mitral valve-in-
valve procedures (and even 1 double valve procedure)
have been reported.4,5 This represents the first description
of successful combination of all these procedures.CLINICAL SUMMARY
A 73-year-old man who had undergone mitral valve re-
construction and bypass surgery 12 years previously was re-
ferred to our clinic. He was in New York Heart Association
functional class IV.
Echocardiography revealed structural degeneration of
the repaired mitral valve with moderate to severe mitral
stenosis (pressure gradient maximum/mean ratio, 21/8; ef-
fective orifice area, 1.3 cm2) and grade II insufficiency.
Additionally, the aortic valve was severely stenosed, witha gradient of 56/30 mm Hg despite his poor left ventricular
function of 18%. There was moderate tricuspid insuffi-
ciency, and pulmonary arterial pressure was 66 mm Hg
greater than central venous pressure. Coronary angiogra-
phy showed patent bypass grafts; however, 2 de novo
lesions of the proximal right coronary artery needed
intervention.
The EuroSCORE was 17 points, with a logistic Euro-
SCORE of 69.4% (Society of Thoracic Surgeons risk
model not available). The heart team chose and the patient
agreed to a hybrid approach with percutaneous coronary
intervention and transapical aortic and mitral valve
implantation.
The aortic annulus was measured at 27 mm with trans-
esophageal echocardiography and computed tomography.
Selection of the mitral valve prosthesis was done by precise
computed tomographic reconstruction of the l ring, which
revealed an inner circumference of 79.5 mm, equaling an
inner diameter of 25.3 mm if pressed into a perfectly round
shape. Thus 29-mm Edwards Sapien XT valves (Edwards
Lifesciences LLC, Irvine, Calif) were selected for both
the aortic and mitral positions.Procedures
Percutaneous coronary intervention with placement of 2
drug-eluting stents in the proximal right coronary artery,
was successfully performed 4 days before the transapical
procedure (Figure 1).ery c August 2012
FIGURE 1. Percutaneous intervention on the proximal right coronary artery. A, Before the intervention. B, After the intervention.
Surgical TechniquesFor the transapical procedure, the apex was exposed
through a left lateral minithoracotomy, and 2 purse-
string sutures plus a temporary pacemaker lead were
placed on the left ventricle. The aortic valve was ad-
dressed first. After antegrade passage of the valve and
placement of a superstiff wire in the descending aorta, val-
vuloplasty with a 24-mm balloon and consecutive valve
implantation were performed under rapid pacing. After
the implantation, blood pressure did not recover, and me-
chanical cardiopulmonary resuscitation was necessary for
2 minutes. The patient recovered without the need for
a heart–lung machine and remained in stable condition
thereafter.
The decision to continue with the mitral valve was made.
The stenosed mitral valve was passed, a 14F sheath wasFIGURE 2. Transapical double valve implantation. A, Initial aortic root shot.
tation. D, Valvuloplasty of the mitral ring. E, Implantation in the mitral positio
The Journal of Thoracic and Cabrought in through the valve, and a stiff wire was placed
in the left atrium. Balloon valvuloplasty was performed
with a 26-mm balloon. The 29-mm valve prosthesis
crimped for the mitral position was placed within the mitral
ring and expanded very slowly, aiming for a position 1 third
in the atrium and 2 thirds in the ventricle (Figure 2). Results
were checked by transesophageal echocardiography, which
showed a perfect result of the aortic valve with no regurgi-
tation and a gradient of 13/7 mm Hg. Mitral valve function
was also good, with 2 trivial jets between the prosthesis and
the ring and a Doppler gradient of 11/4 mm Hg.
With moderate inotropic support, implantation of an
intra-aortic balloon pump was considered. One was not
placed, however, because of the severe peripheral artery dis-
ease and a 85% stenosis of the superior mesenteric artery.B, Implantation in the aortic position. C, Result of the aortic valve implan-
n. F, Final result.
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Surgical TechniquesPostoperative Course
The patient’s condition stabilized, and sedation was dis-
continued the first postoperative day. The patient was free of
inotropic support on day 3 and was successfully extubated.
He showed no neurologic abnormalities and no rhythm dis-
orders. The patient was discharged 20 days postoperatively,
and he was alive and well (New York Heart Association
functional class II) on postoperative day 61.
DISCUSSION
Transcatheter aortic valve implantation as a treatment op-
tion for severe aortic valve stenosis has been a major devel-
opment in cardiovascular medicine of the last 5 years and
has become a routine procedure at many hospitals. Recent
studies have shown encouraging results, especially consid-
ering the high-risk population that has been treated.1,2
Concomitant treatment of coronary artery disease by
percutaneous intervention has been described.3 In addition,
single cases or small series of transcatheter mitral valve-in-
valve procedures, as well as 1 double valve procedure, have
been reported.4,5 The combination of all these procedures,
however, has never before been successfully performed.
The case presented here was thoroughly discussed by
a heart team after conventional surgery was denied. All
involved persons, including the patient, were aware of theFrom the Departments of Pulmonary and Critical Care Medicine,a Cardiothoracic
Surgery,b and Pathology and Immunology,c Michael E. DeBakey VAMedical Cen-
ter, Baylor College of Medicine, Houston, Tex.
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procedure. It was, however, considered the least risky
option for the patient. There was also general agreement
that treating only some of the problems did not have
sufficient potential for symptom relief and might on the
contrary present a risk for slow postoperative recovery.
The procedural planning and conduct of this heart team
provides a good example of how treatment options can be
expanded for patients with a very high operative risk by
good collaboration between cardiologists and cardiac
surgeons.
References
1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Trans-
catheter aortic-valve implantation for aortic stenosis in patients who cannot un-
dergo surgery. N Engl J Med. 2010;363:1597-607.
2. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, et al.
Health-related quality of life after transcatheter aortic valve replacement in inop-
erable patients with severe aortic stenosis. Circulation. 2011;124:1964-72.
3. Mostafa AE, Geist V, Abdel-Wahab M. Ad-hoc percutaneous coronary interven-
tion and transcatheter aortic valve implantation as a combined transfemoral pro-
cedure. J Invasive Cardiol. 2011;23:E102-5.
4. Cheung AW, Gurvitch R, Ye J, Wood D, Lichtenstein SV, Thompson C, et al.
Transcatheter transapical mitral valve-in-valve implantations for a failed biopros-
thesis: a case series. J Thorac Cardiovasc Surg. 2011;141:711-5.
5. Seiffert M, Baldus S, Conradi L, Koschyk D, Schirmer J, Meinertz T, et al. Simul-
taneous transcatheter aortic and mitral valve-in-valve implantation in a patient
with degenerated bioprostheses and high surgical risk. Thorac Cardiovasc Surg.
2011;59:490-2.Treatment of large subglottic tracheal schwannoma with
microdebrider bronchoscopyJose Melendez, MD,a Lorraine Cornwell, MD,b Linda Green, MD,c and Roberto F. Casal, MD,a Houston,
TexPrimary tracheal schwannomas are among the least com-
mon tracheal tumors.1 Although endoscopic treatment
with the Nd:YAG laser has been reported, surgical resection
remains the standard of care.2,3 We report here the
successful use of a novel bronchoscopic technique, themicrodebrider, for the management of a large subglottic
tracheal schwannoma.CLINICAL SUMMARY
A 63-year-old man was referred to our institution for
diagnosis and management of a large endotracheal mass
detected in a computed tomographic scan of the chest dur-
ing evaluation for dyspnea. We performed rigid bronchos-
copy, finding a mass on the posterior wall of the trachea,
2 cm from the vocal cords, with approximately 90%
obstruction of the lumen (Figure 1, A). This mass was ses-
sile, round, and broad based. Endobronchial ultrasonogra-
phy was used to assess the vascularity of the lesion and its
relationship to the esophagus, and to obtain a needle aspi-
ration specimen for preliminary diagnosis. On-site cyto-
logic examination showed a spindle cell tumor. The
patient was considered to be a poor surgical candidateery c August 2012
